2Rename WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure[J]. Eur Heart J,2001,22 : 1527-1560.
3Manohar P, Pina IL. Therapeutic role of angiotensin Ⅱ receptor blockers in the treatment of heart failure [ J ].Mayo Clin Proe, 2003,78: 334-338.
4Zannad F,All a F,Dousset B,et al. Limitation of excessive extracellular matrix tamover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure [ J ]. Circulation, 2000, 102 :2700-2706.
5Satoh M, Nakarnura M, Saitoh H, et al. ALdosterone synthase(CYP11132) expression and myocardial fibrosis in the failing human heart[J]. Clin Sci(Lond),2002,102: 381-386.
6Xiao RP,Zhu W, Zheng M, et al. Subtype-specific β-adrenoceptor signaling pathways in the heart and their potential clinical implications[J]. Trends Pharmacol Sci,2004,25 : 358-365.
7Dendorfer A,Dominiak P, Schunkert H. ACE inhibitors and angiotensin Ⅱ receptor antagonists[J]. Handb Exp Pharmacol,2005,170:407-442.
8Cicoira M,Zanolla A, Rossia A, et al. Failure of aldosterone suppression despite angiotensin-converting enzyme(ACE) inhibitor administration in chronic heart failure in associated with ACE DD genotype[ J ]. J Am Coll Cardiol,2001,37 : 1808-1812.
9Wang XY,Masilamani S,Nielsen J,et al. The renal thiazide-sensitive Na-C1 cotransportor of the aldosterone-escape plenomenon[ J ]. J Clin Invest, 2001,108: 215-222.
10Dieterich HA, Wendt C, Saborowski F. Cardioprotection by aldosterone receptor antagonism in heart failure [ J ].Part I. The role of aldosterone in heart failure. Fiziol Cheloveka, 2005,31:97-105.
1Harjuhahto TA, Leinonen MR, Simola OT. Congestive heart failure and a- trial fibrillation in a cat with myocardial fibro -fatty infiltration[J]. J Fe- line Med Surg, 2011,13 (2) : 109 - 111.
2Eng M, Bansal S. Use of natriuretic- doses of spironolactone for treat- ment of loop diuretic resistant acute decompensated heart failure[J]. Int J Cardiol,2014,170(3) : e68 - e69.
3Patel BM, Bhadada SV. Type 2 diabetes - induced cardiovascular compli- cations: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril [ J ]. Clin Exp Hypertens, 2014,36 (5): 340 - 347.
